论文部分内容阅读
美国药品、食品管理局准备将药品检查机构改组,成立三个新的药品评价办公室,从而使这样的办公室增加到五个。这次改组的目的是通过提高工作效率、密切工作部门之间的关系、改善联络渠道来加快新药审批检查的速度。 1994年9月,药品评价和研究中心宣称,改组、尽管它有一个动议的阶段,但它是要实施的,准备先组建一个改组的框架。目前正等待着卫生和人类服务部对该改组计划的批准。根据该改组计划,第一药品评价办公室将把内科造影、牙外科、胃肠和血凝固等药物
The U.S. Drug and Food Administration is preparing to reorganize drug inspection agencies and set up three new drug evaluation offices to increase the number of such offices to five. The purpose of this reorganization is to speed up the examination and examination of new drugs by increasing the efficiency of work, close relations between working departments, and improving communication channels. In September 1994, the Center for Drug Evaluation and Research declared that although it had a stage for reorganization, it was to be implemented and it was prepared to set up a reorganization framework first. The Ministry of Health and Human Services is currently awaiting approval of the restructuring plan. According to the reorganization plan, the first drug evaluation office will give medicines such as medical imaging, dental surgery, gastrointestinal and blood coagulation.